References
- Ashley J. J., Levy G. Inhibition of diphenylhydantoin elimination by its major metabolite. Research Communications in Chemical Pathology and Pharmacology 1972; 4: 297–306
- Belvedere G., Tognoni G., Morselli P. L. A new sensitive gas-chromatographic method for the determination of fenfluramine in biological specimens. European Journal of Clinical Pharmacology 1972; 5: 62–64
- Benet L. Z., Galeazzi R. L. Noncompartmental determination of the steady-state volume of distribution. Journal of Pharmaceutical Science 1979; 68: 1071–1074
- Bettini E., Ceci A., Spinelli R., Samanin R. Neuroleptic-like effects of the 1-isomer of fenfluramine on striatal dopamine release in freely moving rats. Biochemical Pharmacology 1987; 36: 2387–2391
- Boxenbaum H. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: Extrapolation of data to benzodiazepines and phenytoin. Journal of Pharmacokinetics and Biopharmaceutics 1980; 8: 165–176
- Caccia S., Ballabio M., Guiso G., Rocchetti M., Garattini S. Species differences in the kinetics and metabolism of fenfluramine isomers. Archives Internationales de Pharmacodynamie et de Therapie 1982; 258: 15–28
- Caccia S., Conforti I., Duchier J., Garattini S. Pharmacokinetics of fenfluramine and norfenfluramine in volunteers given d- and dl-fenfluramine for 15 days. European Journal of Clinical Pharmacology 1985; 29: 221–224
- Caccia S., Dagnino G., Garattini S., Guiso G., Madonna R., Zanini M. G. Kinetics of fenfluramine isomers in the rat. European Journal of Drug Metabolism and Pharmacokinetics 1981; 6: 297–301
- Campbell D. B. Pharmacokinetics of Amphetamine and Fenfluramine after Therapeutic Dosage and Overdosage. Ph.D. Thesis, University of London. 1978
- Campbell D. B., Richards R. P., Caccia S., Garattini S. Stereoselective metabolism and the fate of fenfluramine in animals and man. Development of Drugs and Modern Medicines, J. W. Gorrod, G. G. Gibson, M. Mitchard. Horwood, Chichester 1986; 298–311
- Covell D. G., Abbrecht P. H., Berman M. The effect of hepatic uptake on the disappearance of warfarin from the plasma of rats: A kinetic analysis. Journal of Pharmacokinetics and Biopharmaceutics 1983; 11: 127–145
- Debbas N. M. G., Ings R. M. J., Gordon B. H., Richards R. P., Jackson S. H. D., Turner P. (+)-fenfluramine: Relative and absolute bioavailability of a solution compared with a capsule. British Journal of Clinical Pharmacology 1985; 20: 549P
- Fracasso C., Guiso G., Garattini S., Caccia S. Disposition of d-fenfluramine in lean and obese rats. Appetite 1988; 10: 45–55
- Garattini S., Bizzi A., Caccia S., Mennini T., Samanin R. Progress in assessing the role of serotonin in the control of food intake. Clinical Neuropharmacology 1987, in press
- Garattini S., Caccia S., Mennini T., Samanin R., Consolo S., Ladinsky H. Biochemical pharmacology of the anorectic drug fenfluramine: A review. Current Medical Research and Opinion 1979; 6(suppl. 1)15–27
- Geller E., Ritvo E. R., Freerman B. J., Yuwiler A. Preliminary observations on the effect of fenfluramine on blood serotonin and symptoms in three autistic boys. New Zealand Journal of Medicine 1982; 307: 165–169
- Gibaldi M., Perrier D. Pharmacokinetics2nd ed. Marcel Dekker, New York 1982
- Glowinski J., Iversen L. L. Regional studies of catecholamines in the rat brain—I. The disposition of ‘3H’norepinephrine, ‘3H’dopamine and ‘3H’dopa in various regions of the brain. Journal of Neurochemistry 1966; 13: 655–669
- Invernizzi R., Berettera C., Garattini S., Samanin R. D- and 1-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. European Journal of Pharmacology 1986; 120: 9–15
- Lowry O. H., Rosenbrough N. J., Parr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
- Morgan C. D., Cattabeni F., Costa E. Methamphetamine, fenfluramine and their N-dealkylated metabolites: Effect on monoamine concentrations in rat tissues. Journal of Pharmacology and Experimental Therapeutics 1972; 180: 127–134
- Nies A. S., Shand D. G., Wilkinson G. R. Altered hepatic blood flow and drug disposition. Clinical Pharmacokinetics 1976; 1: 135–155
- Pinder R. M., Brogden R. N., Sawyer P. R., Speight T. M., Avery G. S. Fenfluramine: A review of its pharmacological properties and therapeutic efficacy in obesity. Drugs 1975; 10: 241–323
- Ritvo E. R., Freeman B. J., Geller E., Yuwiler A. Effects of fenfluramine on 14 outpatients with the syndrome of autism. Journal of the American Academy of Child Psychiatry 1983; 22: 529–558
- Toon S., Rowland M. Structure-pharmacokinetic relationships among the barbiturates in the rat. Journal of Pharmacology and Experimental Therapeutics 1983; 225: 752–763
- Vermeulen N. P. E., Danhof M., Setiawan I., Thio T. H., Breimer D. D. Disposition of hexobarbital in the rat. Estimation of -first–pass elimination and influence of ether anesthesia. Journal of Pharmacology and Experimental Therapeutics 1983; 226: 201–205
- Weder H. J., Bickel M. H. Interactions of drugs with proteins II: Experimental methods, treatment of experimental data, and thermodynamics of binding reactions of thymoleptic drugs and model dyes. Journal of Pharmaceutical Sciences 1970; 59: 1563–1569
- Whittaker V. P., Barker L. A. The subcellular fractionation of brain tissue with special reference to the preparation of synaptosomes and their component organelles. Methods of Neurochemistry, R. Fried. Marcell Dekker, New York 1972; Vol. 2: 1–50